|
1
|
Izadirad M, Jafari L, James AR, Unfried
JP, Wu ZX and Chen ZS: Long noncoding RNAs have pivotal roles in
chemoresistance of acute myeloid leukemia. Drug Discov Today.
26:1735–1743. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
SEER. Cancer Stat Facts, . Leukemia-Acute
Myeloid Leukemia (AML). 2023.Available from:. https://seer.cancer.gov/statfacts/html/amyl.html
|
|
3
|
Riva L, Luzi L and Pelicci PG: Genomics of
acute myeloid leukemia: The next generation. Front Oncol. 2:402012.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Han HJ, Sung JY, Kim SH, Yun UJ, Kim H,
Jang EJ, Yoo HE, Hong EK, Goh SH, Moon A, et al: Fibronectin
regulates anoikis resistance via cell aggregate formation. Cancer
Lett. 508:59–72. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Adeshakin FO, Adeshakin AO, Afolabi LO,
Yan D, Zhang G and Wan X: Mechanisms for modulating anoikis
resistance in cancer and the relevance of metabolic reprogramming.
Front Oncol. 11:6265772021. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ye G, Yang Q, Lei X, Zhu X, Li F, He J,
Chen H, Ling R, Zhang H, Lin T, et al: Nuclear MYH9-induced CTNNB1
transcription, targeted by staurosporin, promotes gastric cancer
cell anoikis resistance and metastasis. Theranostics. 10:7545–7560.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jin L, Chun J, Pan C, Kumar A, Zhang G, Ha
Y, Li D, Alesi GN, Kang Y, Zhou L, et al: The PLAG1-GDH1 axis
promotes anoikis resistance and tumor metastasis through
CamKK2-AMPK signaling in LKB1-Deficient lung cancer. Mol Cell.
69:87–99.e7. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Buchheit CL, Angarola BL, Steiner A,
Weigel KJ and Schafer ZT: Anoikis evasion in inflammatory breast
cancer cells is mediated by Bim-EL sequestration. Cell Death
Differ. 22:1275–1286. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen J, Gao F and Liu N: L1CAM promotes
epithelial to mesenchymal transition and formation of cancer
initiating cells in human endometrial cancer. Exp Ther Med.
15:2792–2797. 2018.PubMed/NCBI
|
|
10
|
Ruvolo PP, Ma H, Ruvolo VR, Zhang X, Post
SM and Andreeff M: LGALS1 acts as a pro-survival molecule in AML.
Biochim Biophys Acta Mol Cell Res. 1867:1187852020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nie D, Ma P, Chen Y, Zhao H, Liu L, Xin D,
Cao W, Wang F, Meng X, Liu L, et al: MiR-204 suppresses the
progression of acute myeloid leukemia through HGF/c-Met pathway.
Hematology. 26:931–939. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang J, Qi L, Wang T, An J, Zhou B, Fang
Y, Liu Y, Shan M, Hong D, Wu D, et al: FEV maintains homing and
expansion by activating ITGA4 transcription in primary and relapsed
AML. Front Oncol. 12:8903462022. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lou Y, Jiang Y, Liang Z, Liu B, Li T and
Zhang D: Role of RhoC in cancer cell migration. Cancer Cell Int.
21:5272021. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen S, Gu J, Zhang Q, Hu Y and Ge Y:
Development of biomarker signatures associated with anoikis to
predict prognosis in endometrial carcinoma patients. J Oncol.
2021:33752972021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yu G, Wang LG, Han Y and He QY:
clusterProfiler: An R package for comparing biological themes among
gene clusters. OMICS. 16:284–287. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW,
Shi W and Smyth GK: Limma powers differential expression analyses
for RNA-sequencing and microarray studies. Nucleic Acids Res.
43:e472015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wu X, Sui Z, Zhang H, Wang Y and Yu Z:
Integrated analysis of lncRNA-mediated ceRNA network in lung
adenocarcinoma. Front Oncol. 10:5547592020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Friedman J, Hastie T and Tibshirani R:
Regularization paths for generalized linear models via coordinate
descent. J Stat Softw. 33:1–22. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu TT, Li R, Huo C, Li JP, Yao J, Ji XL
and Qu YQ: Identification of CDK2-related immune forecast model and
ceRNA in lung adenocarcinoma, a Pan-cancer analysis. Front Cell Dev
Biol. 9:6820022021. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Heagerty PJ, Lumley T and Pepe MS:
Time-dependent ROC curves for censored survival data and a
diagnostic marker. Biometrics. 56:337–344. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xu J, Yang T, Wu F, Chen T, Wang A and Hou
S: A nomogram for predicting prognosis of patients with cervical
cerclage. Heliyon. 9:e211472023. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
De Kouchkovsky I and Abdul-Hay M: ‘Acute
myeloid leukemia: A comprehensive review and 2016 update’. Blood
Cancer J. 6:e4412016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gu Z, Eils R and Schlesner M: Complex
heatmaps reveal patterns and correlations in multidimensional
genomic data. Bioinformatics. 32:2847–2849. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Maeser D, Gruener RF and Huang RS:
oncoPredict: An R package for predicting in vivo or cancer patient
drug response and biomarkers from cell line screening data. Brief
Bioinform. 22:bbab2602021. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Döhner H, Estey E, Grimwade D, Amadori S,
Appelbaum FR, Büchner T, Dombret H, Ebert BL, Fenaux P, Larson RA,
et al: Diagnosis and management of AML in adults: 2017 ELN
recommendations from an international expert panel. Blood.
129:424–447. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Almond LM, Charalampakis M, Ford SJ,
Gourevitch D and Desai A: Myeloid SArcoma: Presentation, diagnosis,
and treatment. Clin Lymphoma Myeloma Leuk. 17:263–267. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bakir B, Chiarella AM, Pitarresi JR and
Rustgi AK: EMT, MET, plasticity, and tumor metastasis. Trends Cell
Biol. 30:764–776. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jin L, Chun J, Pan C, Alesi GN, Li D,
Magliocca KR, Kang Y, Chen ZG, Shin DM, Khuri FR, et al:
Phosphorylation-mediated activation of LDHA promotes cancer cell
invasion and tumour metastasis. Oncogene. 36:3797–3806. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jiang K, Yao G, Hu L, Yan Y, Liu J, Shi J,
Chang Y, Zhang Y, Liang D, Shen D, et al: MOB2 suppresses GBM cell
migration and invasion via regulation of FAK/Akt and cAMP/PKA
signaling. Cell Death Dis. 11:2302020. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kim H, Choi P, Kim T, Kim Y, Song BG, Park
YT, Choi SJ, Yoon CH, Lim WC, Ko H and Ham J: Ginsenosides Rk1 and
Rg5 inhibit transforming growth factor-β1-induced
epithelial-mesenchymal transition and suppress migration, invasion,
anoikis resistance, and development of stem-like features in lung
cancer. J Ginseng Res. 45:134–148. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang F, Yang L, Xiao M, Zhang Z, Shen J,
Anuchapreeda S, Tima S, Chiampanichayakul S and Xiao Z: PD-L1
regulates cell proliferation and apoptosis in acute myeloid
leukemia by activating PI3K-AKT signaling pathway. Sci Rep.
12:114442022. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kamili NA, Arthur CM, Gerner-Smidt C,
Tafesse E, Blenda A, Dias-Baruffi M and Stowell SR: Key regulators
of galectin-glycan interactions. Proteomics. 16:3111–3125. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li M, Ye J, Xia Y, Li M, Li G, Hu X, Su X,
Wang D, Zhao X, Lu F, et al: METTL3 mediates chemoresistance by
enhancing AML homing and engraftment via ITGA4. Leukemia.
36:2586–2595. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang SH, Wu XC, Zhang MD, Weng MZ, Zhou D
and Quan ZW: Upregulation of H19 indicates a poor prognosis in
gallbladder carcinoma and promotes epithelial-mesenchymal
transition. Am J Cancer Res. 6:15–26. 2016.PubMed/NCBI
|
|
36
|
Chen EC, Gandler H, Tošić I, Fell GG,
Fiore A, Pozdnyakova O, DeAngelo DJ, Galinsky I, Luskin MR,
Wadleigh M, et al: Targeting MET and FGFR in relapsed or refractory
acute myeloid leukemia: Preclinical and clinical findings, and
signal transduction correlates. Clin Cancer Res. 29:878–887. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Guo JR, Li W, Wu Y, Wu LQ, Li X, Guo YF,
Zheng XH, Lian XL, Huang HF and Chen YZ: Hepatocyte growth factor
promotes proliferation, invasion, and metastasis of myeloid
leukemia cells through PI3K-AKT and MAPK/ERK signaling pathway. Am
J Transl Res. 8:3630–3644. 2016.PubMed/NCBI
|
|
38
|
Lawson CD and Ridley AJ: Rho GTPase
signaling complexes in cell migration and invasion. J Cell Biol.
217:447–457. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Stanley A, Thompson K, Hynes A, Brakebusch
C and Quondamatteo F: NADPH oxidase complex-derived reactive oxygen
species, the actin cytoskeleton, and Rho GTPases in cell migration.
Antioxid Redox Signal. 20:2026–2042. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Liu BL, Sun KX, Zong ZH, Chen S and Zhao
Y: MicroRNA-372 inhibits endometrial carcinoma development by
targeting the expression of the Ras homolog gene family member C
(RhoC). Oncotarget. 7:6649–6664. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Knirsh R, Ben-Dror I, Modai S, Shomron N
and Vardimon L: MicroRNA 10b promotes abnormal expression of the
proto-oncogene c-Jun in metastatic breast cancer cells. Oncotarget.
7:59932–59944. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wang YF, Li Z, Zhao XH, Zuo XM, Zhang Y,
Xiao YH, Li J and Peng ZH: MicroRNA-10b is upregulated and has an
invasive role in colorectal cancer through enhanced Rhoc
expression. Oncol Rep. 33:1275–1283. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Sang XB, Zong ZH, Wang LL, Wu DD, Chen S,
Liu BL and Zhao Y: E2F-1 targets miR-519d to regulate the
expression of the ras homolog gene family member C. Oncotarget.
8:14777–14793. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zhou W, Zhang C, Jiang H, Zhang Z, Xie L
and He X: MiR-493 suppresses the proliferation and invasion of
gastric cancer cells by targeting RhoC. Iran J Basic Med Sci.
18:1027–1033. 2015.PubMed/NCBI
|
|
45
|
Heo SK, Noh EK, Kim JY, Jeong YK, Jo JC,
Choi Y, Koh S, Baek JH, Min YJ and Kim H: Targeting c-KIT (CD117)
by dasatinib and radotinib promotes acute myeloid leukemia cell
death. Sci Rep. 7:152782017. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Müller-Tidow C, Bug G, Lübbert M, Krämer
A, Krauter J, Valent P, Nachbaur D, Berdel WE, Ottmann OG, Fritsch
H, et al: A randomized, open-label, phase I/II trial to investigate
the maximum tolerated dose of the Polo-like kinase inhibitor BI
2536 in elderly patients with refractory/relapsed acute myeloid
leukaemia. Br J Haematol. 163:214–222. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Ibrado AM, Kim CN and Bhalla K: Temporal
relationship of CDK1 activation and mitotic arrest to cytosolic
accumulation of cytochrome C and caspase-3 activity during
Taxol-induced apoptosis of human AML HL-60 cells. Leukemia.
12:1930–1936. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Chen YJ, Fang LW, Su WC, Hsu WY, Yang KC
and Huang HL: Lapatinib induces autophagic cell death and
differentiation in acute myeloblastic leukemia. Onco Targets Ther.
9:4453–4464. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Ricciardi MR, Scerpa MC, Bergamo P,
Ciuffreda L, Petrucci MT, Chiaretti S, Tavolaro S, Mascolo MG,
Abrams SL, Steelman LS, et al: Therapeutic potential of MEK
inhibition in acute myelogenous leukemia: Rationale for ‘vertical’
and ‘lateral’ combination strategies. J Mol Med (Berl).
90:1133–1144. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Wang Z, Liu Y, Mo Y, Zhang H, Dai Z, Zhang
X, Ye W, Cao H, Liu Z and Cheng Q: The CXCL family contributes to
immunosuppressive microenvironment in gliomas and assists in
gliomas chemotherapy. Front Immunol. 12:7317512021. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Cao ZX, Guo CJ, Song X, He JL, Tan L, Yu
S, Zhang RQ, Peng F, Peng C and Li YZ: Erlotinib is effective
against FLT3-ITD mutant AML and helps to overcome intratumoral
heterogeneity via targeting FLT3 and Lyn. FASEB J. 34:10182–10190.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Dai Y, Chen S, Wang L, Pei XY, Kramer LB,
Dent P and Grant S: Bortezomib interacts synergistically with
belinostat in human acute myeloid leukaemia and acute lymphoblastic
leukaemia cells in association with perturbations in NF-κB and Bim.
Br J Haematol. 153:222–235. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Rashid A, Duan X, Gao F, Yang M and Yen A:
Roscovitine enhances all-trans retinoic acid (ATRA)-induced nuclear
enrichment of an ensemble of activated signaling molecules and
augments ATRA-induced myeloid cell differentiation. Oncotarget.
11:1017–1036. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Wahner Hendrickson AE, Haluska P,
Schneider PA, Loegering DA, Peterson KL, Attar R, Smith BD,
Erlichman C, Gottardis M, Karp JE, et al: Expression of insulin
receptor isoform A and insulin-like growth factor-1 receptor in
human acute myelogenous leukemia: Effect of the dual-receptor
inhibitor BMS-536924 in vitro. Cancer Res. 69:7635–7643. 2009.
View Article : Google Scholar : PubMed/NCBI
|
